4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
TreatPolyQ – Industrial Academic Initial Training Network towards treatment of Polyglutamine Diseases (TREATPOLYQ)
Date du début: 1 mars 2011, Date de fin: 28 févr. 2015,
Protein aggregation is a hallmark of many late onset neurodegenerative disorders including Parkinson’s Disease (PD), Alzheimer’s Disease (AD), amyotrophic lateral sclerosis (ALS), prion diseases as well as the group of polyglutamine diseases (polyQ). The aim of this proposal is to create a network of European partners bridging important basic mechanisms involved in proteinopathies, research of mod ...
Voir le projet
17
Participants partenaires
TERMINÉ
Development of a novel FGL therapy and translational tests for regenerative treatment of neurological disorders (NEUROFGL)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2014,
Neurodegenerative disorders such as, Alzheimer’s disease (AD), Mild Cognitive Impairment (MCI), stroke, Traumatic Brain Injury (TBI) and chronic stress create a major economic burden to society and a substantial reduction in quality of life for patients and families. The development of neuroregenerative therapies is notoriously difficult and requires significant investment. NeuroFGL will contribut ...
Voir le projet
7
Participants partenaires
TERMINÉ
A IAPP on the Role of NCAM in Stem Cell Differentiation (STEMCAM)
Date du début: 1 sept. 2010, Date de fin: 31 août 2014,
...ardial lineage, in comparison with embryonic stem cells. The project will take advantage of very unique and innovative pharmacological tools, the NCAM and growth factor mimetic peptides discovered by ENKAM. To achieve its aim STEMCAM will apply an interdisciplinary approach from cell biology (including innovative in vitro culture using bi- and three dimensional systems), immunocytochemistry, imagi ...
Voir le projet
6
Participants partenaires
TERMINÉ
Synaptic mechanisms of memory loss: novel cell adhesion molecules as therapeutic targets (MemStick)
Date du début: 1 févr. 2008, Date de fin: 30 avr. 2011,
Memory loss is a central symptom in different diseases, and represents a significant social and economic burden for a large percentage of European citizens. The molecular and neurobiological bases of memory deficits are largely unknown and there are currently no drugs available that can markedly decelerate or prevent memory decline. To address this major problem, this project will investigate the ...
Voir le projet